Breaking News

Takeda to Transport Products Between Europe and the U.S. with Sailing Cargo Vessels

Takeda will transport its products using VELA’s new fleet of next-generation sailing cargo vessels, powered 100 percent by wind when at sea.

Author Image

By: Charlie Sternberg

Associate Editor

Takeda has partnered with VELA Transport to become the first biopharmaceutical company to transport its products between Europe and the U.S. using VELA’s new fleet of next-generation sailing cargo vessels, powered 100 percent by wind when at sea. Purpose-built to handle pharmaceutical products, VELA will offer reliable, secure and ultra-low-emission sea freight shipping. The maiden voyage is planned for late 2026. View this post on Instagram A post shared by VELA • Sail for...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters